logo

Latest news

New publication by Kashkar et al. in The EMBO Journal

Abstract

Cellular inhibitor of apoptosis proteins (cIAPs) are RING-containing E3 ubiquitin ligases that ubiquitylate receptor-interacting protein…

SFB 1530 Seminar Series: Arnon Kater

Arnon Kater's research covers the broad spectrum of fundamental, pre-clinical and translational studies, focussing on the (immune)biology and…

New publication in Science Advances: cFLIP and cell death

The Annibaldi lab's study on the role of cFLIP cleavage in the regulation of cell death is now online on Science Advances

New preprint of the Pallasch lab: Pentose Phosphate Pathway Inhibition activates Macrophages towards phagocytic Lymphoma Cell Clearance

Macrophages in the B-cell lymphoma microenvironment represent a functional node in progression and therapeutic response. We assessed metabolic…

SFB 1530 Seminar Series: Caroline Pabst (Heidelberg University Hospital)

About Caroline Pabst, MD

Caroline Pabst is a clinician researcher at Heidelberg University Hospital and leader of the Max-Eder Junior Research Group…

SFB 1530 Diversity Coffee Break

Take a coffee break with the Inclusivity, Diversity and Gender committee!

New publication in The New England Journal of Medicine

The latest study of the German CLL Study Group shows that Venetoclax–obinutuzumab with or without ibrutinib was superior to chemoimmunotherapy as…

SFB 1530 Seminar Series kickoff: Martin Dreyling (LMU Munich)

Our first guest speaker for the series is Prof. Martin Dreyling from LMU Munich.

 

The aim of the SFB 1530 Seminar Series is to develop an…

New publication in Nature Communications

New publication of project C04 in B-cell lymphoma and CLL: Transcriptomic profiles and 5-year results from the randomized CLL14 study of venetoclax…

Christian_Reinhardt - SFB1530

Christian Reinhardt receives the German Cancer Award 2023

The CRC1530 group leader was awarded the German Cancer Award 2023 in "Experimental Oncological Research" by the German Cancer Society.

Read more here…